NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and ...
•Genomic characterization determines diagnosis, classification, and prognostication of the myeloid malignancies myelodysplastic syndrome (MDS) and AML. •Recognizing genetic lesions as invariable ...
Therapeutic efforts in acute myeloid leukemia (AML) face persistent challenges due to diverse and unstable cell populations within and between tumors. Previous studies have investigated how specific ...
Patient and disease characteristics of women with acute myelogenous leukemia (AML) and a history of breast cancer (BC). Background: Frequency of h-AML is 5%-7% among adult patients with AML. Most ...
—Classifying myelodysplastic syndrome and secondary acute myeloid leukemia by genetic mutations rather than strictly by blast count may allow more patients to be eligible for AML and MDS clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results